Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04882319 · ClinicalTrials.gov registry record · Phase 1
Irritation and Sensitization Study of HP-5000 Topical System
A Phase 1 study, sponsored by Noven Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 200
- Enrollment target
NCT04882319: Completed Phase 1 study, sponsored by Noven Pharmaceuticals.
NCT04882319 is a Phase 1 study that has completed, run by Noven Pharmaceuticals. The registered enrollment target is 200 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (233% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04882319, a Phase 1 study, has completed, sponsored by Noven Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 200 participants
- Enrollment target
Study Summary
This study will assess skin irritation and sensitization for HP-5000 patch in healthy subjects.
Interventions
- DRUG HP-5000 Topical Patch
- DRUG HP-5000 Placebo Patch
- DRUG Saline Patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2021-06-03 |
| Est. Completion | 2022-03-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04882319
The ClinicalTrials.gov registry entry for NCT04882319 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (233% higher). The listed sponsor is Noven Pharmaceuticals, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which HP-5000 Topical Patch is the first listed.
NCT04882319 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04882319 about?
NCT04882319 is a clinical study titled "Irritation and Sensitization Study of HP-5000 Topical System". This study will assess skin irritation and sensitization for HP-5000 patch in healthy subjects.
What is the current status of trial NCT04882319?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 200 participants. The study started on 2021-06-03. Estimated completion is 2022-03-11.
What interventions are being tested in trial NCT04882319?
The interventions under investigation include: HP-5000 Topical Patch (DRUG), HP-5000 Placebo Patch (DRUG), Saline Patch (DRUG).
Who is sponsoring clinical trial NCT04882319?
This trial is sponsored by Noven Pharmaceuticals, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.